Mikhail S. Chesnokov
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
GATA4 loss promotes mutant Kras-driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions.
Journal: bioRxiv : the preprint server for biology
Published: June 05, 2026
A matter of new life and cell death: programmed cell death in the mammalian ovary.
Journal: Journal of biomedical science
Published: September 29, 2023
Favorable outcomes of NPM1mut AML patients are due to transcriptional inactivation of FOXM1, presenting a new target to overcome chemoresistance.
Journal: Blood cancer journal
Published: June 03, 2023
Drug toxicity assessment: cell proliferation versus cell death.
Journal: Cell death discovery
Published: August 11, 2022
FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML.
Journal: Frontiers in oncology
Published: April 16, 2021
Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells.
Journal: Cell death & disease
Published: February 17, 2021
Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma.
Journal: PeerJ
Published: January 10, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026